Aug 1, 2008 By:
J. Brooker Aker
|
Here's how to search for meaning through unstructured data.

Jul 16, 2008 By:
George Koroneos, Online Content & News Editor
|
The Johnson & Johnson subsidiary launched an unbranded support group page on social networking site Facebook giving moms of kids with ADHD a place to learn, but not a place to converse.

Jul 10, 2008 By:
George Koroneos, Online Content & News Editor
|
Johnson & Johnson launched its healthcare video channel on Google?s YouTube, signaling pharma?s further entrenchment into the online community

May 14, 2008 By:
George Koroneos, Online Content & News Editor
|
The Hershey Center for Applied Research is bringing social networking to researchers and academics with a new platform that could become a Facebook for the life science community. Does the site, dubbed KnowledgeMesh, have what it takes cut through the Web 2.0 clutter? Pharm Exec takes a closer look.

May 14, 2008 By:
George Koroneos, Online Content & News Editor
|
Rather than wait to see which ePedigree legislation becomes law, biotech firm Genzyme has taken the initiative and implemented an electronic track-and-trace program to clamp down on fake meds.

May 7, 2008 By:
George Koroneos, Online Content & News Editor
|
Still hoping the journal article on your drug's adverse reactions will go unnoticed? Think again. A new partnership between medical journals and physician social networking site Sermo just made chatting about drugs a lot easier.

May 1, 2008 By:
Jill Van Bos, Milliman
|
Pharmacoactuarial analysis helps drug companies communicate value to health plans

Apr 30, 2008 By:
George Koroneos, Online Content & News Editor
|
Bill Gates and Co. officially released Office for Business Applications (OBA) for the life sciences industry. This set of tools allows software developers to build applications that seamlessly connect back-end enterprise systems with MS Office programs.

Apr 30, 2008 By:
George Koroneos, Online Content & News Editor
|
New bipartisan bill calls for the standardization of an electronic pedigree across the US pharma supply chain. Is this a good thing, or just more work for pharma?
